Friday, November 22, 2024
HomeTagsEsophageal precancer

esophageal precancer

Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer

Lucid Diagnostics Inc, a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed In , announced that, the MolDX Program published a Future Effective...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics